Veverimer
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02809183)
Timeline
Indications
Mechanism of action
- Hydrochloric acidSEQUESTERING AGENT
Hydrochloric acid sequestering agent
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298196 ↗
Also known as
- trc101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04984226 | Phase 2 | Dec 1, 2021 | University of California, Davis, Vanderbilt University |
| NCT03710291 | Phase 3 | Nov 20, 2018 | Tricida, Inc. |
| NCT03390842 | Phase 3 | Dec 20, 2017 | Tricida, Inc. |
| NCT03317444 | Phase 3 | Sep 26, 2017 | Tricida, Inc. |
| NCT02809183 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2016 | Tricida, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tricida, Inc. | For profit | 4 | 4 | 2 | 2016 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1